EADV News Issue 80

Scientific Programme Committee

Skin Barrier and Microbiome Dr Chris Callewaert 02 October 2021 15:45 - 16:45 Recent sequencing technologies have opened a multitude of possibilities in investigating the microbiome on and in the human body. In recent years, we have gained unprecedented information on the skin microbiome and its correlation with skin conditions. It was already clear that the skin microbiome can have an impact in acne vulgaris, atopic dermatitis, rosacea and dandruff; now we have also discovered changes in topical microbiome in psoriasis, alopecia and even skin cancer. It still remains to be determined whether the microbiome is a cause or consequence in the skin condition. Exciting new therapies are being developed to counteract the microbiome dysbiosis state on skin and, as such, restore the skin to its healthy state. In this session, we have presentations from top researchers that show the promise of this rapidly growing field.

Cosmeceuticals Prof Elena Araviiskaia, MD, PhD 02 October 2021 15:45 - 16:45 In recent decades, the cosmetic industry has undergone crucial changes as a result of growing knowledge about normal and diseased skin physiology. New research techniques and testing methodologies are continually being developed and the search for novel active ingredients, based on well-understood mechanisms of action, is ongoing. Cosmetic products are used alone or alongside pharmacological treatment for photoprotection, correction of xerosis and aged or sensitive skin. Modern dermocosmetics has today become a routine part of themanagement of patients with inflammatory skin diseases: atopic dermatitis, acne, rosacea, psoriasis, etc. Our session focuses on dermocosmetics in healthy and diseased skin in broad dermatological practice. We will look at the modern attitude toward the use of cosmetics in acne and rosacea. Important aspects of skin care in newborns and aged skin, based on up-to-date knowledge of skin barriers, will also be presented. Finally, we will also demonstrate the focus on modern photoprotection, its regulatory aspects and the impact of sunscreens on the environment and health.

Dermoscopy Assoc. Prof Aimilios Lallas 30 September 2021 15:45 - 16:45 The diagnostic landscape in dermatology is rapidly changing and new experience- based updates come to light every day. Recent exciting developments in skin imaging and artificial intelligence (AI) indicate that the field will be even more dynamic in the near future. The sessions devoted to dermoscopy will provide a concise update of clinically relevant evidence, encouraging clinicians to apply this new knowledge in practice. In the dermoscopy session I chair, we will hear the latest information on how to discriminate in situ from invasive squamous cell carcinoma developing on the skin or on mucosa. Attendees will also learn to recognise difficult basal cell carcinomas at an early stage. Dermoscopy today is used not only to assess skin tumours, but across the entire spectrum of dermatologic diseases. One of the most popular applications of dermoscopy is trichoscopy. In the session, we will hear an updated presentation of the basics required to evaluate hair disorders with a hand-held or digital dermatoscope. We will also discuss the always challenging management of Spitzoid-looking lesions, in the light of recent evidence that might be considered as practice-changing.


Made with FlippingBook flipbook maker